HD Labs Tirzepatide 30mg is a dual GIP + GLP-1 receptor agonist. 
Benefits:
Strong appetite suppression
Good blood sugar control
Fast fat loss
Less food noise / cravings
How it works:
Slows gastric emptying
Increases satiety
Improves insulin sensitivity
Features:
Fat loss (especially stubborn belly fat)
Insulin resistance / pre-diabetes
Ideal for people who have plateaued with Semaglutide
Do not use if:
You have a history of pancreatitis
Gallbladder disease
Medullary thyroid cancer (MEN2)
Severe GI sensitivity
Administration:
Subcutaneous
Sites: Belly (most effective), thigh or back of upper arm
Frequency: Once weekly, same day each week
Time: Any time of day (consistency matters more)
Dosage:
Always start on lowest recommended dosage
Weeks 1–4
2.5 mg once weekly
Weeks 5–8
5 mg once weekly
Weeks 9–12
7.5 mg once weekly (optional)
Most fat loss happens 5–7.5 mg. Higher is not better, just harsher.
Experienced GLP-1 User (Semaglutide before)
Weeks 1–2
5 mg weekly
Weeks 3–6
7.5 mg weekly
Weeks 7–12
10 mg max if tolerated
Higher dosages greatly increases nausea/side effects with little extra fat loss.
Expected Results:
Appetite drop: Week 1–2
Scale weight drop: Week 2–4
Visible fat loss: Week 4–6
Common side effects:
Nausea
Constipation
Reflux
Reduce side effects by: 
Eating slower and smaller meals
Avoiding fatty/fried foods
Staying hydrated
Adding electrolytes
Prioritize protein intake
Do not crash calories
Improved results when combined with healthy diet and exercise